{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:28:29Z","timestamp":1785731309673,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470639, 81670542"],"award-info":[{"award-number":["82470639, 81670542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019618","name":"Fujian Provincial Key Laboratory for the Development of Bioactive Material from Marine Algae, Quanzhou Normal University","doi-asserted-by":"publisher","award":["2021Y0001"],"award-info":[{"award-number":["2021Y0001"]}],"id":[{"id":"10.13039\/501100019618","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Provincial Natural Science Foundation Project","award":["2021J011351"],"award-info":[{"award-number":["2021J011351"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08144-8","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:13:03Z","timestamp":1776697983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peptide aptamer sP10 targeting NPM1 attenuates liver fibrosis and hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Xian","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Le","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1213-0550","authenticated-orcid":false,"given":"Song-Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"8144_CR1","doi-asserted-by":"publisher","first-page":"2245491","DOI":"10.1155\/2022\/2245491","volume":"2022","author":"J Wen","year":"2022","unstructured":"Wen J, Chen X, Wei S, Ma X, Zhao Y. Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia. Evid Based Complement Alternat Med. 2022;2022:2245491.","journal-title":"Evid Based Complement Alternat Med"},{"key":"8144_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","volume":"70","author":"C Lackner","year":"2019","unstructured":"Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol. 2019;70:294\u2013304.","journal-title":"J Hepatol"},{"key":"8144_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749\u201361.","journal-title":"Lancet"},{"key":"8144_CR4","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/516S2a","volume":"516","author":"L Laursen","year":"2014","unstructured":"Laursen L. A preventable cancer. Nature. 2014;516:S2\u20133.","journal-title":"Nature"},{"key":"8144_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jhep.2021.11.013","volume":"76","author":"D D\u2019Avola","year":"2022","unstructured":"D\u2019Avola D, Granito A, Torre-Alaez M, Piscaglia F. The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma. J Hepatol. 2022;76:1185\u201398.","journal-title":"J Hepatol"},{"key":"8144_CR6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.20488","volume":"40","author":"MC Yu","year":"2004","unstructured":"Yu MC, Chen CH, Liang XY, Wang LF, Gandhi CR, Fung JJ, Lu L, et al. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004;40:1312\u201321.","journal-title":"Hepatology"},{"key":"8144_CR7","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/hep.23953","volume":"52","author":"R Chinnadurai","year":"2010","unstructured":"Chinnadurai R, Grakoui A. B7-H4 Mediates Inhibition of T Cell Responses by Activated Murine Hepatic Stellate Cells. Hepatology. 2010;52:2177\u201385.","journal-title":"Hepatology"},{"key":"8144_CR8","doi-asserted-by":"publisher","first-page":"e1700167","DOI":"10.1002\/pmic.201700167","volume":"18","author":"A Santi","year":"2018","unstructured":"Santi A, Kugeratski FG, Zanivan S. Cancer Associated Fibroblasts: The Architects of Stroma Remodeling. Proteomics. 2018;18:e1700167.","journal-title":"Proteomics"},{"key":"8144_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cas.14262","volume":"111","author":"R Zhang","year":"2020","unstructured":"Zhang R, Gao X, Zuo J, Hu B, Yang J, Zhao J, Chen J. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Cancer Sci. 2020;111:406\u201317.","journal-title":"Cancer Sci"},{"key":"8144_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1097\/TP.0b013e31818bfd13","volume":"86","author":"GP Jiang","year":"2008","unstructured":"Jiang GP, Yang HR, Wang LF, Wildey GM, Fung J, Qian SG, Lu L. Hepatic Stellate Cells Preferentially Expand Allogeneic CD4(+)CD25(+)FoxP3(+) Regulatory T Cells in an IL-2-Dependent Manner. Transplantation. 2008;86:1492\u2013502.","journal-title":"Transplantation"},{"key":"8144_CR11","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.4049\/jimmunol.1201937","volume":"190","author":"RM Dunham","year":"2013","unstructured":"Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B, Grakoui A. Hepatic Stellate Cells Preferentially Induce Foxp3(+) Regulatory T Cells by Production of Retinoic Acid. J Immunol. 2013;190:2009\u201316.","journal-title":"J Immunol"},{"key":"8144_CR12","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1038\/onc.2009.253","volume":"28","author":"F van Zijl","year":"2009","unstructured":"van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, Eferl R, et al. Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene. 2009;28:4022\u201333.","journal-title":"Oncogene"},{"key":"8144_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1349-7006.2009.01087.x","volume":"100","author":"T Amann","year":"2009","unstructured":"Amann T, Bataille F, Spruss T, Muhlbauer M, Gabele E, Scholmerich J, Kiefer P, et al. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci. 2009;100:646\u201353.","journal-title":"Cancer Sci"},{"key":"8144_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372.","journal-title":"Physiol Rev"},{"key":"8144_CR15","doi-asserted-by":"crossref","unstructured":"Ding X, Zhu XL, Xu DH, Li S, Yang Q, Feng X, Wei YG et al. NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-\u03b22. Cell Death Dis. 2023;14.","DOI":"10.1038\/s41419-023-06043-0"},{"key":"8144_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biocel.2015.07.007","volume":"66","author":"B Peng","year":"2015","unstructured":"Peng B, Liu F, Han R, Luo G, Cathopoulis T, Lu K, Li X, et al. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells. Int J Biochem Cell Biol. 2015;66:45\u201358.","journal-title":"Int J Biochem Cell Biol"},{"key":"8144_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3892\/ijo.2016.3580","volume":"49","author":"K Lu","year":"2016","unstructured":"Lu K, Liu GY, Yang L, Liu F, Gao LB, Shi JX, Deng XL, et al. Sustainable inflammation transforms hepatic cells by causing oxidative stress injury and potential epithelial-mesenchymal transition. Int J Oncol. 2016;49:971\u201380.","journal-title":"Int J Oncol"},{"key":"8144_CR18","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1002\/jcb.26135","volume":"118","author":"GY Liu","year":"2017","unstructured":"Liu GY, Shi JX, Shi SL, Liu F, Rui G, Li X, Gao LB, et al. Nucleophosmin Regulates Intracellular Oxidative Stress Homeostasis via Antioxidant PRDX6. J Cell Biochem. 2017;118:4697\u2013707.","journal-title":"J Cell Biochem"},{"key":"8144_CR19","doi-asserted-by":"publisher","first-page":"106233","DOI":"10.1016\/j.biocel.2022.106233","volume":"147","author":"D Wang","year":"2022","unstructured":"Wang D, Li Y, Liu Y, Cheng S, Liu F, Zuo R, Ding C, et al. NPM1 promotes cell proliferation by targeting PRDX6 in colorectal cancer. Int J Biochem Cell Biol. 2022;147:106233.","journal-title":"Int J Biochem Cell Biol"},{"key":"8144_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10735-006-9040-y","volume":"37","author":"RA Gjerset","year":"2006","unstructured":"Gjerset RA. DNA damage, p14ARF, nucleophosmin (NPM\/B23), and cancer. J Mol Histol. 2006;37:239\u201351.","journal-title":"J Mol Histol"},{"key":"8144_CR21","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/carcin\/bgm025","volume":"28","author":"J Li","year":"2007","unstructured":"Li J, Sejas DP, Burma S, Chen DJ, Pang Q. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability. Carcinogenesis. 2007;28:1163\u201370.","journal-title":"Carcinogenesis"},{"key":"8144_CR22","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1038\/onc.2012.227","volume":"32","author":"Z Li","year":"2013","unstructured":"Li Z, Hann SR. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription. Oncogene. 2013;32:1988\u201394.","journal-title":"Oncogene"},{"key":"8144_CR23","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1002\/jcb.25971","volume":"118","author":"X Li","year":"2017","unstructured":"Li X, Xu DH, Liu F, Liu GY, Lu K, Deng XL, Li QF, et al. Relocation of NPM Affects the Malignant Phenotypes of Hepatoma SMMC-7721 Cells. J Cell Biochem. 2017;118:3225\u201336.","journal-title":"J Cell Biochem"},{"key":"8144_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3892\/ijo.2014.2407","volume":"45","author":"DH Xu","year":"2014","unstructured":"Xu DH, Liu F, Li X, Chen XF, Jing GJ, Wu FY, Shi SL, et al. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells. Int J Oncol. 2014;45:264\u201372.","journal-title":"Int J Oncol"},{"key":"8144_CR25","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3892\/mmr.2017.6246","volume":"15","author":"F Luo","year":"2017","unstructured":"Luo F, Li H, Liang J, Jia H, Li X, Xiao H, He X, et al. Downregulation of NPM reverses multidrug resistance in human hepatoma cells via inhibition of P-glycoprotein expression. Mol Med Rep. 2017;15:2360\u20138.","journal-title":"Mol Med Rep"},{"key":"8144_CR26","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/hep.26209","volume":"57","author":"SJ Lo","year":"2013","unstructured":"Lo SJ, Fan LC, Tsai YF, Lin KY, Huang HL, Wang TH, Liu H, et al. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells. Hepatology. 2013;57:1893\u2013905.","journal-title":"Hepatology"},{"key":"8144_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ymthe.2020.01.012","volume":"28","author":"KC Liu","year":"2020","unstructured":"Liu KC, Xie F, Zhao TT, Zhang R, Gao AD, Chen YY, Li HY, et al. Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma. Mol Ther. 2020;28:901\u201313.","journal-title":"Mol Ther"},{"key":"8144_CR28","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","volume":"36","author":"R Ranieri","year":"2022","unstructured":"Ranieri R, Pianigiani G, Sciabolacci S, Perriello VM, Marra A, Cardinali V, Pierangeli S, et al. Current status and future perspectives in targeted therapy of mutated AML. Leukemia. 2022;36:2351\u201367.","journal-title":"Leukemia"},{"key":"8144_CR29","first-page":"1766","volume":"13","author":"LY Hu","year":"2023","unstructured":"Hu LY, Gong PG, Zhou N, Wang SL, He C, Zhou YX, Li QW, et al. NPM1 promotes nasopharyngeal carcinoma metastasis and stemness by recruiting Mdm2 to induce the ubiquitination-mediated degradation of p53. Am J Cancer Res. 2023;13:1766\u2013.","journal-title":"Am J Cancer Res"},{"key":"8144_CR30","doi-asserted-by":"crossref","unstructured":"Wang D, Li Y, Liu YL, Cheng SY, Liu F, Zuo RJ, Ding CC et al. NPM1 promotes cell proliferation by targeting PRDX6 in colorectal cancer. Int J Biochem Cell Biol 2022;147.","DOI":"10.1016\/j.biocel.2022.106233"},{"key":"8144_CR31","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1002\/ptr.7236","volume":"35","author":"S Gopalakrishnan","year":"2021","unstructured":"Gopalakrishnan S, Ismail A. Aromatic monophenols from cinnamon bark act as proteasome inhibitors by upregulating ER stress, suppressing FoxM1 expression, and inducing apoptosis in prostate cancer cells. Phytother Res. 2021;35:5781\u201394.","journal-title":"Phytother Res"},{"key":"8144_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.freeradbiomed.2023.08.027","volume":"208","author":"M Kim","year":"2023","unstructured":"Kim M, Bae JY, Yoo S, Kim HW, Lee SA, Kim ET, Koh G. 2-Deoxy-D-ribose induces ferroptosis in renal tubular epithelial cells via ubiquitin-proteasome system-mediated xCT protein degradation. Free Radic Biol Med. 2023;208:384\u201393.","journal-title":"Free Radic Biol Med"},{"key":"8144_CR33","doi-asserted-by":"crossref","unstructured":"Lin X, Zhao RH, Bin Y, Huo RH, Xue G, Wu JF. TIMP1 promotes thyroid cancer cell progression through macrophage phenotypic polarization via the PI3K\/AKT signaling pathway. Genomics. 2024;116.","DOI":"10.1016\/j.ygeno.2024.110914"},{"key":"8144_CR34","doi-asserted-by":"crossref","unstructured":"Scialpi R, Espinosa-Sotelo R, Bertran E, Dituri F, Giannelli G, Fabregat I. New Hepatocellular Carcinoma (HCC) primary cell cultures as models for exploring personalized anti-TGF-\u03b2 therapies based on tumor characteristics. Int J Mol Sci. 2025;26.","DOI":"10.3390\/ijms26062430"},{"key":"8144_CR35","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1158\/0008-5472.CAN-22-3631","volume":"83","author":"KR Sekhar","year":"2023","unstructured":"Sekhar KR, Freeman ML. Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment. Cancer Res. 2023;83:1573\u201380.","journal-title":"Cancer Res"},{"key":"8144_CR36","doi-asserted-by":"crossref","unstructured":"Wang ZB, Pan BL, Yao YX, Qiu JC, Zhang XX, Wu XX, Tang NH. XPO1 intensifies sorafenib resistance by stabilizing acetylation of NPM1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinoma. Biomed Pharmacother. 2023;160.","DOI":"10.1016\/j.biopha.2023.114402"},{"key":"8144_CR37","doi-asserted-by":"crossref","unstructured":"Song XD, Shi JY, Liu JT, Liu Y, Yu Y, Qiu YF, Cao ZQ et al. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-\u03b2\/Smad pathway. Mol Med. 2022;28.","DOI":"10.1186\/s10020-022-00508-2"},{"key":"8144_CR38","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1038\/onc.2008.54","volume":"27","author":"W Qi","year":"2008","unstructured":"Qi W, Shakalya K, Stejskal A, Goldman A, Beeck S, Cooke L, Mahadevan D. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene. 2008;27:4210\u201320.","journal-title":"Oncogene"},{"key":"8144_CR39","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/1535-7163.MCT-08-1056","volume":"8","author":"Y Pereira","year":"2009","unstructured":"Pereira Y, Farina HG, Gil J, Rodriguez A, Benavent F, Castellanos L, G\u00f3mez RE, et al. Anticancer peptide CIGB-300 binds to nucleophosmin\/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Mol Cancer Ther. 2009;8:1189\u201396.","journal-title":"Mol Cancer Ther"},{"key":"8144_CR40","doi-asserted-by":"crossref","unstructured":"Garay H, Espinosa LA, Perera Y, S\u00e1nchez A, Diago D, Perea SE, Besada V et al. Characterization of low-abundance species in the active pharmaceutical ingredient of CIGB-300: a clinical-grade anticancer synthetic peptide. J Pept Sci. 2018;24.","DOI":"10.1002\/psc.3081"},{"key":"8144_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jb\/mvm222","volume":"143","author":"M Okuwaki","year":"2008","unstructured":"Okuwaki M. The structure and functions of NPM1\/Nucleophsmin\/B23, a multifunctional nucleolar acidic protein. J BioChem. 2008;143:441\u20138.","journal-title":"J BioChem"},{"key":"8144_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13287-024-03898-8","volume":"15","author":"P Wang","year":"2024","unstructured":"Wang P, Wang M, Liu L, Li H, Liu H, Ren J, Liu T, et al. Targeting NPM1 inhibits proliferation and promotes apoptosis of hepatic progenitor cells via suppression of mTOR signalling pathway. Stem Cell Res Ther. 2024;15:292.","journal-title":"Stem Cell Res Ther"},{"key":"8144_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11010-008-9814-5","volume":"316","author":"SE Perea","year":"2008","unstructured":"Perea SE, Reyes O, Baladron I, Perera Y, Farina H, Gil J, Rodriguez A, et al. CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo. Mol Cell Biochem. 2008;316:163\u20137.","journal-title":"Mol Cell Biochem"},{"key":"8144_CR44","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/1535-7163.MCT-08-1056","volume":"8","author":"Y Perera","year":"2009","unstructured":"Perera Y, Farina HG, Gil J, Rodriguez A, Benavent F, Castellanos L, Gomez RE, et al. Anticancer peptide CIGB-300 binds to nucleophosmin\/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Mol Cancer Ther. 2009;8:1189\u201396.","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08144-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:30:05Z","timestamp":1780443005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08144-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8144"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08144-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8746134\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"725"}}